1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)

C168H330N22 — CID 157193486

IUPAC1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)
SMILESCC(C)/C1=C/CCN(C(C)C)CCC1.CC(C)C1/C=C\CN(C(C)C)CCC1.CC(C)C1=CN(C(C)C)C=CC=C1.CC(C)C1C/C=C\N(C(C)C)CCC1.CC(C)C1C/C=C\N(C(C)C)CCC1.CC(C)C1CCCN(C(C)C)CCC1.CC(C)N1/C=C\CN(C(C)C)CCC1.CC(C)N1/C=C\CN(C(C)C)CCC1.CC(C)N1C=CC=CN(C(C)C)C1.CC(C)N1C=CCCN(C(C)C)C1.CC(C)N1C=CCCN(C(C)C)C1.CC(C)N1CC=CCN(C(C)C)C1.CC(C)N1CCCCN(C(C)C)C1.CC(C)N1CCCN(C(C)C)CCC1
InChIInChI=1S/C13H27N.4C13H25N.C12H26N2.2C12H24N2.C12H19N.C11H24N2.3C11H22N2.C11H20N2/c8*1-11(2)13-7-5-9-14(12(3)4)10-6-8-13;6*1-10(2)12-7-5-6-8-13(9-12)11(3)4/h11-13H,5-10H2,1-4H3;7,11-12H,5-6,8-10H2,1-4H3;2*5,9,11-13H,6-8,10H2,1-4H3;5,7,11-13H,6,8-10H2,1-4H3;11-12H,5-10H2,1-4H3;2*5,7,11-12H,6,8-10H2,1-4H3;5-11H,1-4H3;10-11H,5-9H2,1-4H3;2*5,7,10-11H,6,8-9H2,1-4H3;5-6,10-11H,7-9H2,1-4H3;5-8,10-11H,9H2,1-4H3/b;13-7+;2*9-5-;7-5-;;2*7-5-;;;;;;
InChIKeyAPYWRUJOHFLCCR-HMVZGFNWSA-N
MW2658.64 g/mol
LogP38.89
Rot. Bonds28

About 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)

1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine) (PubChem CID 157193486) has the molecular formula C168H330N22 and a molecular weight of 2658.64 g/mol. Its IUPAC name is 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine).

Molecular Properties

Compound Name1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)
PubChem CID157193486
Molecular FormulaC168H330N22
Molecular Weight2658.64 g/mol
Exact Mass2656.65
IUPAC Name1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)
SMILESCC(C)/C1=C/CCN(C(C)C)CCC1.CC(C)C1/C=C\CN(C(C)C)CCC1.CC(C)C1=CN(C(C)C)C=CC=C1.CC(C)C1C/C=C\N(C(C)C)CCC1.CC(C)C1C/C=C\N(C(C)C)CCC1.CC(C)C1CCCN(C(C)C)CCC1.CC(C)N1/C=C\CN(C(C)C)CCC1.CC(C)N1/C=C\CN(C(C)C)CCC1.CC(C)N1C=CC=CN(C(C)C)C1.CC(C)N1C=CCCN(C(C)C)C1.CC(C)N1C=CCCN(C(C)C)C1.CC(C)N1CC=CCN(C(C)C)C1.CC(C)N1CCCCN(C(C)C)C1.CC(C)N1CCCN(C(C)C)CCC1
InChIInChI=1S/C13H27N.4C13H25N.C12H26N2.2C12H24N2.C12H19N.C11H24N2.3C11H22N2.C11H20N2/c8*1-11(2)13-7-5-9-14(12(3)4)10-6-8-13;6*1-10(2)12-7-5-6-8-13(9-12)11(3)4/h11-13H,5-10H2,1-4H3;7,11-12H,5-6,8-10H2,1-4H3;2*5,9,11-13H,6-8,10H2,1-4H3;5,7,11-13H,6,8-10H2,1-4H3;11-12H,5-10H2,1-4H3;2*5,7,11-12H,6,8-10H2,1-4H3;5-11H,1-4H3;10-11H,5-9H2,1-4H3;2*5,7,10-11H,6,8-9H2,1-4H3;5-6,10-11H,7-9H2,1-4H3;5-8,10-11H,9H2,1-4H3/b;13-7+;2*9-5-;7-5-;;2*7-5-;;;;;;
InChIKeyAPYWRUJOHFLCCR-HMVZGFNWSA-N
XLogP38.89
TPSA71.28 Ų
H-Bond Donors
H-Bond Acceptors22
Rotatable Bonds28
Heavy Atoms190
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002658.64
LogP ≤ 538.89
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)?
The IUPAC name of 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine) (CID 157193486) is 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine).
What is the SMILES notation for 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)?
The canonical SMILES for 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine) is CC(C)/C1=C/CCN(C(C)C)CCC1.CC(C)C1/C=C\CN(C(C)C)CCC1.CC(C)C1=CN(C(C)C)C=CC=C1.CC(C)C1C/C=C\N(C(C)C)CCC1.CC(C)C1C/C=C\N(C(C)C)CCC1.CC(C)C1CCCN(C(C)C)CCC1.CC(C)N1/C=C\CN(C(C)C)CCC1.CC(C)N1/C=C\CN(C(C)C)CCC1.CC(C)N1C=CC=CN(C(C)C)C1.CC(C)N1C=CCCN(C(C)C)C1.CC(C)N1C=CCCN(C(C)C)C1.CC(C)N1CC=CCN(C(C)C)C1.CC(C)N1CCCCN(C(C)C)C1.CC(C)N1CCCN(C(C)C)CCC1.
What is the InChIKey of 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)?
The InChIKey is APYWRUJOHFLCCR-HMVZGFNWSA-N. The full InChI is InChI=1S/C13H27N.4C13H25N.C12H26N2.2C12H24N2.C12H19N.C11H24N2.3C11H22N2.C11H20N2/c8*1-11(2)13-7-5-9-14(12(3)4)10-6-8-13;6*1-10(2)12-7-5-6-8-13(9-12)11(3)4/h11-13H,5-10H2,1-4H3;7,11-12H,5-6,8-10H2,1-4H3;2*5,9,11-13H,6-8,10H2,1-4H3;5,7,11-13H,6,8-10H2,1-4H3;11-12H,5-10H2,1-4H3;2*5,7,11-12H,6,8-10H2,1-4H3;5-11H,1-4H3;10-11H,5-9H2,1-4H3;2*5,7,10-11H,6,8-9H2,1-4H3;5-6,10-11H,7-9H2,1-4H3;5-8,10-11H,9H2,1-4H3/b;13-7+;2*9-5-;7-5-;;2*7-5-;;;;;;.
What are the key properties of 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine)?
1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine) has a molecular weight of 2658.64 g/mol, XLogP of 38.89, 28 rotatable bonds, 0 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 1,3-di(propan-2-yl)azepine;1,5-di(propan-2-yl)azocane;1,3-di(propan-2-yl)-1,3-diazepane;1,3-di(propan-2-yl)-2H-1,3-diazepine;1,5-di(propan-2-yl)-1,5-diazocane;bis(1,3-di(propan-2-yl)-4,5-dihydro-2H-1,3-diazepine);1,3-di(propan-2-yl)-4,7-dihydro-2H-1,3-diazepine;(5E)-1,5-di(propan-2-yl)-3,4,7,8-tetrahydro-2H-azocine;(6Z)-1,5-di(propan-2-yl)-3,4,5,8-tetrahydro-2H-azocine;bis((7Z)-1,5-di(propan-2-yl)-3,4,5,6-tetrahydro-2H-azocine);bis((7Z)-1,5-di(propan-2-yl)-2,3,4,6-tetrahydro-1,5-diazocine) is sourced from PubChem (CID 157193486), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).